Related references
Note: Only part of the references are listed.Sorafenib Plus Hepatic ArterialInfusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized TriaL
Kanglian Zheng et al.
RADIOLOGY (2022)
Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Young Eun Ahn et al.
GUT AND LIVER (2021)
Hepatic Arterial Infusion Chemotherapy with Modified FOLFOX as an Alternative Treatment Option in Advanced Hepatocellular Carcinoma Patients with Failed or Unsuitability for Transarterial Chemoembolization
Shu-Jung Hsu et al.
ACADEMIC RADIOLOGY (2021)
Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
Hideki Iwamoto et al.
CANCERS (2021)
Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naive patients: a propensity score matching analysis
Irene Bargellini et al.
EUROPEAN RADIOLOGY (2021)
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma
Sojung Han et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy
Takeshi Terashima et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Ferroptosis, necroptosis, and pyroptosis in anticancer immunity
Rong Tang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Hepatic arterial infusion chemotherapy vs transcatheter arterial embolization for patients with huge unresectable hepatocellular carcinoma
Wei-Lun Tsai et al.
MEDICINE (2020)
Transarterial chemoembolization with hepatic arterial infusion chemotherapy plus S-1 for hepatocellular carcinoma
Jian-Hai Guo et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
The safety and efficacy of lenvatinib combined with immune checkpoint inhibitors therapy for advanced hepatocellular carcinoma
Yun Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Association between ADAMTS13 activity-VWF antigen imbalance and the therapeutic effect of HAIC in patients with hepatocellular carcinoma
Hiroaki Takaya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Efficacy and safety of hepatic arterial infusion chemotherapy combined with transarterial embolization for unresectable hepatocellular carcinoma: A propensity score-matching cohort study
Wenbo Guo et al.
JGH OPEN (2020)
The Early Decline of α-Fetoprotein and Des-γ-Carboxy Prothrombin Predicts the Response of Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma Patients
Shumpei Yamamoto et al.
GASTROINTESTINAL TUMORS (2020)
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion A Randomized Clinical Trial
MinKe He et al.
JAMA ONCOLOGY (2019)
Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma
Pil Soo Sung et al.
ANTICANCER RESEARCH (2019)
Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
Issei Saeki et al.
PLOS ONE (2019)
Evaluation of the assessment for continuous treatment with hepatic arterial infusion chemotherapy scoring system in patients with advanced hepatocellular carcinoma
Issei Saeki et al.
HEPATOLOGY RESEARCH (2018)
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
Masahiro Hatooka et al.
BMC CANCER (2018)
High expression of CD44v9 and xCT in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazine
Fumitaka Wada et al.
CANCER SCIENCE (2018)
Comparison of hepatic arterial infusion chemotherapy between 5-fluorouracil-based continuous infusion chemotherapy and low-dose cisplatin monotherapy for advanced hepatocellular carcinoma
Tomokazu Kawaoka et al.
HEPATOLOGY RESEARCH (2018)
Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis
Kenichiro Kodama et al.
ONCOLOGY (2018)
Transcatheter hepatic arterial infusion chemotherapy vs sorafenib in the treatment of patients with hepatocellular carcinoma of Barcelona Clinic Liver Cancer stage C: a meta-analysis of Asian population
Jia-Yan Ni et al.
ONCOTARGETS AND THERAPY (2018)
Efficacy of bi-monthly hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
Kei Moriya et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
Efficacy of sequential sorafenib plus hepatic arterial infusion chemotherapy in patients with Barcelona Clinic Liver Cancer stage B and C hepatocellular carcinoma: a retrospective single-institution study
Shinichi Ikuta et al.
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY (2018)
Combination of neutrophil-to-lymphocyte ratio and early des--carboxyprothrombin change ratio as a useful predictor of treatment response for hepatic arterial infusion chemotherapy against advanced hepatocellular carcinoma
Seiji Tsunematsu et al.
HEPATOLOGY RESEARCH (2017)
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
Eishiro Mizukoshi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Efficacy and safety of cTACE versus DEB-TACE in patients with hepatocellular carcinoma: a meta-analysis
Jing Huai Zou et al.
JOURNAL OF DIGESTIVE DISEASES (2016)
PD-L1+ MDSCs are increased in HCC patients and induced by soluble factor in the tumor microenvironment
Tomoaki Iwata et al.
SCIENTIFIC REPORTS (2016)
Subclassification of BCLC B Stage Hepatocellular Carcinoma and Treatment Strategies: Proposal of Modified Bolondi's Subclassification (Kinki Criteria)
Masatoshi Kudo et al.
DIGESTIVE DISEASES (2015)
Validation of a Modified Substaging System (Kinki Criteria) for Patients with Intermediate-Stage Hepatocellular Carcinoma
Tadaaki Arizumi et al.
ONCOLOGY (2015)
Hepatic artery infusion chemotherapy for advanced hepatocellular carcinoma
Myeong Jun Song
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Current Status of Hepatic Arterial Infusion Chemotherapy
Shuntaro Obi et al.
LIVER CANCER (2015)
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
R. Golfieri et al.
BRITISH JOURNAL OF CANCER (2014)
Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
Hiroki Nishikawa et al.
Cancers (2012)
Intra-arterial therapy with cisplatin suspension in lipiodol and 5-fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis
H. Nagamatsu et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Share Paper
